(Q34360360)
Statements
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease (English)
Steven I Park
Jaideep Shenoi
John M Pagel
Don K Hamlin
D Scott Wilbur
Nural Orgun
Aimee L Kenoyer
Shani Frayo
Amanda Axtman
Yukang Lin
Darrell R Fisher
Damian J Green
11 August 2010
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference